| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.24 | 1e-07 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.13 | 3e-05 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.15 | 7e-05 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0002 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0002 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.25 | 0.0003 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0005 |